Furthermore, our findings, revealing the ability of the ETAR/ZEB1 axis to control EMT-associated GSDME functions in breast and colon cancer cells, suggest exploring ETAR blockade to counteract nuclear transcriptional activities and metastatic progression in other tumor histotypes overexpressing ETAR. Here, ZEB1 is linked to malignant colon neoplasm.